Literature DB >> 15222485

Expression of delta-lactoferrin induces cell cycle arrest.

Mathilde Breton1, Christophe Mariller, Monique Benaïssa, Katia Caillaux, Edith Browaeys, Maryse Masson, Jean-Pierre Vilain, Joël Mazurier, Annick Pierce.   

Abstract

Delta-lactoferrin (deltaLf) mRNA is the product of alternative splicing of the Lf gene. It has been found in normal tissues and was reported to be absent from their malignant counterparts. Our recent investigations have shown that deltaLf expression is a good prognostic indicator in human breast cancer. However, deltaLf has up till now only been identified as a transcript, and in order to characterize the deltaLf protein and determine its function we have used a deltaLf cDNA construct to produce the protein in vitro and in vivo. A 73 kDa protein was immunoprecipitated from in vitro translation products and this molecular weight is in accordance with the use of the first in frame AUG start codon located in exon 2. We also produced a cell line expressing deltaLf under doxycycline induction. Using this model we have been able to show that deltaLf is mainly distributed in the cytoplasm. Its expression induces cell cycle arrest and inhibits cell proliferation. Our results suggest that deltaLf may play an important role in the regulation of normal cell growth.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15222485     DOI: 10.1023/b:biom.0000027712.81056.13

Source DB:  PubMed          Journal:  Biometals        ISSN: 0966-0844            Impact factor:   2.949


  6 in total

1.  O-GlcNAcylation/phosphorylation cycling at Ser10 controls both transcriptional activity and stability of delta-lactoferrin.

Authors:  Stéphan Hardivillé; Esthelle Hoedt; Christophe Mariller; Monique Benaïssa; Annick Pierce
Journal:  J Biol Chem       Date:  2010-04-19       Impact factor: 5.157

2.  The N1 domain of human lactoferrin is required for internalization by caco-2 cells and targeting to the nucleus.

Authors:  Yasushi A Suzuki; Henry Wong; Kin-Ya Ashida; Anthony B Schryvers; Bo Lönnerdal
Journal:  Biochemistry       Date:  2008-09-12       Impact factor: 3.162

Review 3.  Cellular iron metabolism in prognosis and therapy of breast cancer.

Authors:  Suzy V Torti; Frank M Torti
Journal:  Crit Rev Oncog       Date:  2013

4.  Loss of caveolin-3 induces a lactogenic microenvironment that is protective against mammary tumor formation.

Authors:  Federica Sotgia; Mathew C Casimiro; Gloria Bonuccelli; Manran Liu; Diana Whitaker-Menezes; Ozlem Er; Kristin M Daumer; Isabelle Mercier; Agnieszka K Witkiewicz; Carlo Minetti; Franco Capozza; Michael Gormley; Andrew A Quong; Hallgeir Rui; Philippe G Frank; Janet N Milliman; Erik S Knudsen; Jie Zhou; Chenguang Wang; Richard G Pestell; Michael P Lisanti
Journal:  Am J Pathol       Date:  2009-02       Impact factor: 4.307

5.  Modification by SUMOylation Controls Both the Transcriptional Activity and the Stability of Delta-Lactoferrin.

Authors:  Adelma Escobar-Ramirez; Anne-Sophie Vercoutter-Edouart; Marlène Mortuaire; Isabelle Huvent; Stephan Hardivillé; Esthelle Hoedt; Tony Lefebvre; Annick Pierce
Journal:  PLoS One       Date:  2015-06-19       Impact factor: 3.240

6.  SILAC-based proteomic profiling of the human MDA-MB-231 metastatic breast cancer cell line in response to the two antitumoral lactoferrin isoforms: the secreted lactoferrin and the intracellular delta-lactoferrin.

Authors:  Esthelle Hoedt; Karima Chaoui; Isabelle Huvent; Christophe Mariller; Bernard Monsarrat; Odile Burlet-Schiltz; Annick Pierce
Journal:  PLoS One       Date:  2014-08-12       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.